The latest earning release did not meet the criteria of “stop the bleeding”.
While it is in positive trend, it lacks the immediate or guidance of being “break even”
As a matter or fact, the recurred 300k per quarter is only assured for 12 months.
Company needs to provide further guidance to justify a base of 14 cents.
The recurred dental business identified lacks the “beefy” volume and sustained duration to justify a 5 cents bump
Note last quarter PR mentioned “plurality” opportunities while result indicates “singular”
All and all, it is a disappointment for those who believe LQMT PPS is justified for non CE business. I am still waiting for the financial justification from the non CE bull.
Until then, it is still the FOMO game for CE.
Don’t expect CE opportunity to be announced at any 10Q